Skip to main content
. 2020 Jul 21;10:362. doi: 10.3389/fcimb.2020.00362

Figure 2.

Figure 2

Evaluation of Per2 expression in circulating HPC. (A) Representative flow cytometry contour plots of CD34+CD45+/low cells from whole blood of HIV+ patients. In the square the percentage of CD34+Per2+ cells is shown. To set Per-2 positive/negative gate, we used a mix of antibodies containing CD34–APC and the secondary antibody Alexa 488 without Per2 primary antibody. (B) Histograms show the median and range percentage of CD34+Per2+ cells of HD and HIV-infected patients. Mann–Whitney test, *p < 0.05; HD, healthy donors (n = 32), HIV + patients with CD4 T cells count <500 (n = 27), HIV + patients with CD4 T cells count >500 (n = 26). (C) Linear regression analysis between RTL of CFC derived cells and % CD34+Per2+ cells (r = 0.6, p = 0.04).